Genedrive PLC Director/PDMR Shareholding (7445Y)
December 07 2017 - 10:28AM
UK Regulatory
TIDMGDR
RNS Number : 7445Y
Genedrive PLC
07 December 2017
Notification and public disclosure of transactions by persons
discharging
managerial responsibilities and persons closely associated with
them
genedrive plc (LSE: GDR) ("genedrive" or the "Company"), the
near patient molecular diagnostics company, announces that it has
granted share options ("Options") to certain of its directors and
senior management to acquire a total of 156,087 ordinary shares of
1.5p each in the capital of the Company under the Company's newly
adopted 2017 Share Option Scheme.
The Options have been granted with an exercise price equal to
the close price on the day before grant and vest after a period of
three years. The Options will vest after 3 years only if certain
performance criteria are met. The Options are exercisable over the
period of 10 years from the date of grant.
The information set out below is provided in accordance with the
requirements of Article 19(3) of the EU Market Abuse Regulation No
596/2014.
1. Details of the person discharging managerial
responsibilities / person closely associated
--- -------------------------------------------------------------------------------
a. Name 1. Gordon Powell
2. Gino Miele
3. Nancy Neilson
--- ------------------------------ -----------------------------------------------
2. Reason for the notification
--- -------------------------------------------------------------------------------
a. Position/status 1. Commercial Director
2. R&D Director
3. Quality Assurance Director
--- ------------------------------ -----------------------------------------------
a. Initial notification Initial notification
/Amendment
--- ------------------------------ -----------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -------------------------------------------------------------------------------
a. Name genedrive plc
--- ------------------------------ -----------------------------------------------
b. LEI 213800ZYODIRZ87Y4K14
--- ------------------------------ -----------------------------------------------
4. Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -------------------------------------------------------------------------------
a. Description Options over ordinary shares of
of the 1.5 pence each
Financial
instrument,
type
of instrument
Identification
code
--- ------------------------------ -----------------------------------------------
b. Nature of Grant of options pursuant to and
the transaction in accordance with the terms of
the Company's Share Option Scheme
dated 29 November 2017.
--- ------------------------------ -----------------------------------------------
c. Price(s) Price(s) Option Volume(s)
and volume(s) price(s)
-------------------- ---------- ----------
Gordon Powell 36.0p 88,063
-------------------- ---------- ----------
Gino Miele 36.0p 43,024
-------------------- ---------- ----------
Nancy Neilson 36.0p 25,000
-------------------- ---------- ----------
--- ------------------------------ -----------------------------------------------
d. Aggregated
information N/A
* Aggregated volume
* Price
--- ------------------------------ -----------------------------------------------
e. Date of the 2017-12-07; UTC time
transaction
--- ------------------------------ -----------------------------------------------
f. Place of Outside trading venue - shares
the transaction to be admitted to AIM market of
London Stock Exchange plc on exercise
of options
--- ------------------------------ -----------------------------------------------
For further details please contact:
genedrive plc +44 (0)161 989 0245
David Budd: CEO
Matthew Fowler: CFO
Peel Hunt LLP +44 (0)207 418 8900
James Steel
Oliver Jackson
Consilium Strategic Communications +44 (0)203 709 5700
Chris Gardner
Matthew Neal
Laura Thornton
genedrive@consilium-comms.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEAKAXEAKXFFF
(END) Dow Jones Newswires
December 07, 2017 11:28 ET (16:28 GMT)
Genedrive (LSE:GDR)
Historical Stock Chart
From Apr 2024 to May 2024
Genedrive (LSE:GDR)
Historical Stock Chart
From May 2023 to May 2024